Recruiting
Phase 2

Pembro, GVD

Sponsor:

Michael Spinner, MD

Code:

NCT07021989

Conditions

Hodgkin Lymphoma, Adult

Refractory Hodgkin Lymphoma

Classic Hodgkin Lymphoma

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Pembrolizumab

Non-investigational, involved site radiotherapy (ISRT)

Gemcitabine

Vinorelbine

Liposomal Doxorubicin

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2026-08-25. This information was provided to ClinicalTrials.gov by Michael Spinner, MD on 2026-08-20.